Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons drs. J.M. van Rooijen

Publicaties

Managed Clinical Network for esophageal cancer enables reduction of variation between hospitals trends in treatment strategies, lead time, and 2-year survival

Genomic landscape and actionable targets as identified by whole genome sequencing and RNA sequencing in patients with advanced renal cell carcinoma

Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study

High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer

Optimizing systemic therapy in metastatic breast cancer: implementation in daily practice and exploration of new drug targets

Androgen receptor expression inversely correlates with immune cell infiltration in human epidermal growth factor receptor 2-positive breast cancer

Use of trastuzumab for HER2-positive metastatic breast cancer in daily practice: A population-based study focusing on the elderly

A 21-Year-Old Patient With a HER2-Positive Colorectal Cancer

Immunotherapeutic options on the horizon in breast cancer treatment

Lees meer